# Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/rfa-md-22-003-technologies-for-improving-minority-health-and-eliminating/  
Official notice: https://www.grants.gov/search-results-detail/337225

> National Institutes of Health offered grants to small businesses. Applications closed on April 4, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-MD-22-003 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | April 4, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.307, 93.350 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

## What the grant funds

This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined populations experiencing health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable.

## Questions people ask

### Is RFA-MD-22-003 still open?

No. It closed on April 4, 2022.

### Who can apply for Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)?

Closed April 4, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-MD-22-003?

NIH RePORTER lists 3 projects funded under RFA-MD-22-003 in fiscal 2023 to 2026, at 3 institutions. The most were at Lifegene-Biomarks, Inc., Applied Universal Dynamics Corporation, Penderia Technologies, Inc.

### Who has won Minority Health and Health Disparities Research  grants before?

The largest recipients over five fiscal years were The Johns Hopkins University, The Trustees of Columbia University in the City of New York, University of Hawaii. The program made 1,237 awards worth $2.0 billion in that time.